Paid Clinical Trials in Margate, FL
As of June 2026, 66 paid clinical trials are recruiting in Margate, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Margate offers studies at sites including D&H Cancer Research Center for conditions such as Advanced Solid Tumor, Atopic Dermatitis, Crohn's Disease, Lumbar Spinal Stenosis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Margate
Trials by drug in Margate
Filter results
66 clinical trials
↓ Download CSVA Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Prospective Study to Assess a Diagnostic Aid for Cancer
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
About research studies in Margate
Margate has approximately 66 recruiting research studies across a wide range of therapeutic areas. Florida hosts major research centers including Mayo Clinic Jacksonville, Moffitt Cancer Center, University of Miami Health System, and Nicklaus Children's Hospital, with strong programs in oncology and cardiovascular research.
Top Research Study Locations in Margate
Researchers run research studies in Margate, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| D&H Cancer Research Center | Advanced Solid Tumor, HER2-negative Breast Cancer Patients With Brain Metastases, Head and Neck Squamous Cell Carcinoma | 5 |
| Life Clinical Trials | Overweight or Obesity, Plaque Psoriasis, Psoriatic Arthritis | 5 |
| D&H Cancer Research Center LLC | Advanced Solid Tumor, COVID-19 Infection, HER2-positive Advanced Solid Tumor | 4 |
| D&H Pompano Research Center | Diabetic Kidney Disease (DKD), Tophaceous Gout, Plasma Cell Myeloma Refractory | 4 |
| IVF Florida Reproductive Associates | Chaotic Aneuploidy, Complex Aneuploidy, Infertility (IVF Patients) | 3 |
| Atlantic Medical Research | Ulcerative Colitis, Crohn's Disease | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| D&H National Research Center | Melanoma, Multiple Myeloma (MM), Non-small Cell Lung Cancer | 2 |
| Gsi Clinical Research | Atopic Dermatitis, Atopic Dermatitis (AD), Eczema, Atopic | 2 |
| South Florida Clinical Research | Atherosclerotic Cardiovascular Disease, Obesity, Obesity or Overweight | 2 |
| Life Clinical Trials - Colonial Drive - Margate | Rheumatoid Arthritis, Dry Eye Syndrome, Systemic Lupus Erythematosus | 2 |
| Arthritis & Rheumatology Center of South Florida | Rheumatoid Arthritis | 1 |
| Arthritis and Rheumatology Center of South Florida | Lumbar Spinal Stenosis, Sciatica Acute | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
| D & H Cancer Research Center | iO Resistant sqNSCLC | 1 |
| D and H Cancer Research Center | Metastatic Colorectal Cancer | 1 |
| D&H Cancer Research Center LLC - 1153 | Non Small Cell Lung Cancer | 1 |
| D&H Cancer Research Center, LLC | Metastatic Castration-Resistant Prostate Cancer | 1 |
| D&H National Research Centers - Cancer Research Center, LLC | Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma | 1 |
| D&H National Research Centers, LLC | Hepatocellular Carcinoma (HCC) | 1 |
| D&H Pompano Research Center, LLC | Major Depressive Disorder | 1 |
| DH Cancer Research Center LLC | Primary Evans Syndrome (ES), Primary Immune Thrombocytopenia (ITP) | 1 |
| GSI Clinical Research, LLC | Alopecia Areata | 1 |
| GSI Clinical Research, LLC | Atopic Dermatitis | 1 |
| Investigative Site | Cancer Weight Loss | 1 |
Active & Upcoming Studies in Margate (2026)
Recruiting trials in Margate grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (19 active studies)
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma · Phase 1 · Shanghai Henlius Biotech
- Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma · Phase 1 · Shanghai Henlius Biotech
Diabetes & metabolic (6 active studies)
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) · Phase 3 · Amgen
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
Vaccines (1 active study)
Common conditions studied in Margate
- Advanced Solid Tumor (3 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atopic Dermatitis (3 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
- Crohn's Disease (2 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Lumbar Spinal Stenosis (2 active studies). Recruiting Lumbar Spinal Stenosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non Small Cell Lung Cancer (2 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Rheumatoid Arthritis (2 active studies). Rheumatoid arthritis studies test JAK inhibitors, biologic DMARDs, and novel immunomodulators for moderate to severe disease.
Leading research sponsors in Margate
- AbbVie
- Pfizer
- Sanofi
- Amgen
- AstraZeneca
Local regulations and guidelines
Clinical trials in Florida are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Florida research must also comply with the Florida Information Protection Act (FIPA) and additional oversight from the Florida Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Margate. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Margate
Hipa.ai aggregates every recruiting study in Margate from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Margate?
There are approximately 66 recruiting clinical trials in Margate, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Margate pay participants?
Most recruiting trials in Margate compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Margate?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Margate?
The most common conditions under active study in Margate include Advanced Solid Tumor (3), Atopic Dermatitis (3), Crohn's Disease (2), Lumbar Spinal Stenosis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Margate?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Margate on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Margate?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Margate?
Recruiting research sites in Margate include D&H Cancer Research Center, Life Clinical Trials, D&H Cancer Research Center LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Margate right now?
The largest active categories in Margate are Cancer & tumors (19), Diabetes & metabolic (6), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.